In vitro release of gentamicin from OHAp/PEMA/PMMA samples.
The influence of hydroxyapatite (OHAp) and gentamicin sulphate (GEN) contents on the release kinetics of GEN, in samples composed of OHAp, poly(methyl methacrylate) (PMMA) and poly(ethyl methacrylate) (PEMA) has been studied. For this purpose, samples with 30 and 40% of OHAp and 5 and 9% of GEN were prepared. The in vitro release study was carried out soaking the samples in simulated body fluid (SBF) at 37 degrees C for 70 days. The release profiles showed a faster release during the first 10 h, diminishing progressively until the end of the study. It was noticed that the percentage of released GEN increased with the OHAp content. For samples with 40% of OHAp, GEN release is nearly independent of the initial amount of such drug (in the range 5-9%), whereas for samples with 30% of OHAp, the release process is favoured by higher contents of GEN, which would favour a higher SBF uptake. GEN release is related to SBF uptake, which is in turn related, on the one hand, to the OHAp content (increase of the porosity and the hydrophilic character of the samples) and on the other hand, to content of GEN.
Padilla
S
S
Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
del Real
R P
RP
Vallet-Regí
M
M
D003692:Delayed-Action Preparations / Q000493:pharmacokinetics; D017886:Durapatite / Q000493:pharmacokinetics*; D005839:Gentamicins / Q000493:pharmacokinetics*; D008768:Methylmethacrylates / Q000493:pharmacokinetics*; D019904:Polymethyl Methacrylate / Q000493:pharmacokinetics*
D003692:Delayed-Action Preparations; D005839:Gentamicins; D008768:Methylmethacrylates; C009931:poly(ethylmethacrylate); D019904:Polymethyl Methacrylate; D017886:Durapatite